Huanlin Wu

913 total citations · 1 hit paper
38 papers, 681 citations indexed

About

Huanlin Wu is a scholar working on Molecular Biology, Complementary and alternative medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Huanlin Wu has authored 38 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Complementary and alternative medicine and 15 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Huanlin Wu's work include Traditional Chinese Medicine Analysis (11 papers), Lipid metabolism and disorders (4 papers) and Traditional Chinese Medicine Studies (4 papers). Huanlin Wu is often cited by papers focused on Traditional Chinese Medicine Analysis (11 papers), Lipid metabolism and disorders (4 papers) and Traditional Chinese Medicine Studies (4 papers). Huanlin Wu collaborates with scholars based in China, Thailand and Australia. Huanlin Wu's co-authors include Huiliang Qiu, Bingxin Wu, Shujun Xu, Zhiwei Huang, Tao-Hua Lan, Wei Liu, Xiaoling Chen, Shufeng Zhou, Shulin Wu and Yaomin Du and has published in prestigious journals such as Scientific Reports, Biochimica et Biophysica Acta (BBA) - Biomembranes and Journal of Ethnopharmacology.

In The Last Decade

Huanlin Wu

38 papers receiving 677 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis

2021 210 citations Huanlin Wu et al. profile →

Peers

Huanlin Wu

CCM

PRM

CAM

Xiaohu Chen China

Xiaoyi Bao China

Danli Yang China

Yanbin Gao China

Dazhuo Shi China

Liqing Jiang China

Chunquan Yu China

Pei Zhao China

Pinfang Kang China

Xiaohu Chen China

Huanlin Wu

429 ×1.3

114 ×0.5

CCM

90 ×0.6

PRM

136 ×1.0

135 ×1.3

CAM

Citations per year, relative to Huanlin Wu Huanlin Wu (= 1×) peers Xiaohu Chen

Countries citing papers authored by Huanlin Wu

Since Specialization

Citations

This map shows the geographic impact of Huanlin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huanlin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huanlin Wu more than expected).

Fields of papers citing papers by Huanlin Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huanlin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huanlin Wu. The network helps show where Huanlin Wu may publish in the future.

Co-authorship network of co-authors of Huanlin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Huanlin Wu. A scholar is included among the top collaborators of Huanlin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huanlin Wu. Huanlin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Kai‐Lin, et al.. (2025). Protective effect of Salvianolic acid B against atherosclerosis: a preclinical systematic review and meta-analysis. Frontiers in Pharmacology. 16. 1548811–1548811. 1 indexed citations

Lin, Pei, Zifei Qin, Xinya Zhang, et al.. (2025). Deciphering the effective components of a TCM formula for atherosclerosis by three-dimensional pattern recognition of exogenous components correlated with endogenous metabolites. Journal of Ethnopharmacology. 346. 119647–119647. 1 indexed citations

Qiu, Ruijin, et al.. (2024). Core outcome sets for myocardial infarction in clinical trials of traditional Chinese medicine and Western medicine. Journal of Evidence-Based Medicine. 17(1). 86–94. 5 indexed citations

Zhang, Xiaoxiao, et al.. (2023). The predictive value of machine learning for mortality risk in patients with acute coronary syndromes: a systematic review and meta-analysis. European journal of medical research. 28(1). 451–451. 8 indexed citations

Lin, Pei, et al.. (2023). Pharmacokinetics integrated with network pharmacology to clarify effective components and mechanism of Wendan decoction for the intervention of coronary heart disease. Journal of Ethnopharmacology. 314. 116669–116669. 9 indexed citations

Zhang, Jianzhen, et al.. (2021). [Therapeutic effect of auriculotherapy with miniature bian needle on anxiety in the patients after percutaneous coronary intervention].. PubMed. 46(10). 880–4. 3 indexed citations

Zou, Dezhi, et al.. (2021). Hesperetin inhibits foam cell formation and promotes cholesterol efflux in THP-1-derived macrophages by activating LXRα signal in an AMPK-dependent manner. Journal of Physiology and Biochemistry. 77(3). 405–417. 15 indexed citations

Qiu, Huiliang, Jin Ma, Xiaoqing Li, et al.. (2021). Deciphering mechanism of the herbal formula WuShen in the treatment of postinfarction heart failure. Phytomedicine. 95. 153878–153878. 3 indexed citations

Mao, Shuai, et al.. (2018). Shenzhu Guanxin Recipe Granules (参术冠心方颗粒) for Improving Exercise Tolerance in Patients with Stable Angina (SERIES Trial): A Protocol of Multicenter, Randomized, Double-Blind, Placebo Parallel Controlled Clinical Trial. Chinese Journal of Integrative Medicine. 25(2). 96–102. 3 indexed citations

10.

Qiu, Huiliang, Jin Ma, Huanlin Wu, & Chunhua Ding. (2018). DL-3-n-butylphthalide improves ventricular function, and prevents ventricular remodeling and arrhythmias in post-MI rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 391(6). 627–637. 14 indexed citations

11.

Jin, Xiao, et al.. (2018). Relationship between short telomere length and stroke. Medicine. 97(39). e12489–e12489. 29 indexed citations

12.

Lan, Tao-Hua, et al.. (2018). Systems Pharmacology Dissection of Traditional Chinese Medicine Wen‐Dan Decoction for Treatment of Cardiovascular Diseases. Evidence-based Complementary and Alternative Medicine. 2018(1). 5170854–5170854. 9 indexed citations

13.

Qiu, Huiliang, Wei Liu, Zhaoyu Lu, et al.. (2018). Chronic Kidney Disease Increases Atrial Fibrillation Inducibility: Involvement of Inflammation, Atrial Fibrosis, and Connexins. Frontiers in Physiology. 9. 1726–1726. 35 indexed citations

14.

Wu, Huanlin, et al.. (2017). MiR-196a2 rs11614913 polymorphism could not influence coronary artery disease risk in Asians. Biomedical Research-tokyo. 28(12). 5580–5582. 2 indexed citations

15.

Chen, Yaoxu, et al.. (2017). Attenuation of ischemia/reperfusion-induced inhibition of the rapid component of delayed rectifier potassium current by Isosteviol through scavenging reactive oxygen species. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1859(12). 2447–2453. 11 indexed citations

16.

Zou, Dezhi, et al.. (2017). Traditional Chinese Medicine ShenZhuGuanXin Granules Mitigate Cardiac Dysfunction and Promote Myocardium Angiogenesis in Myocardial Infarction Rats by Upregulating PECAM‐1/CD31 and VEGF Expression. Evidence-based Complementary and Alternative Medicine. 2017(1). 5261729–5261729. 13 indexed citations

17.

Qiu, Huiliang, Huanlin Wu, Jin Ma, et al.. (2017). DL-3-n-Butylphthalide reduces atrial fibrillation susceptibility by inhibiting atrial structural remodeling in rats with heart failure. Naunyn-Schmiedeberg s Archives of Pharmacology. 391(3). 323–334. 23 indexed citations

18.

Wu, Huanlin, et al.. (2015). Effect of Shenzhu Guanxin Recipe (参术冠心方) on patients with angina pectoris after percutaneous coronary intervention: A prospective, randomized controlled trial. Chinese Journal of Integrative Medicine. 21(6). 408–416. 14 indexed citations

19.

Wu, Huanlin, Yunfei Wang, Junzhe Li, et al.. (2014). A Multicentre Randomized Clinical Trial on Efficacy and Safety of Huxin Formula in Patients Undergoing Percutaneous Coronary Intervention. Evidence-based Complementary and Alternative Medicine. 2014(1). 143064–143064. 5 indexed citations

20.

Jiang, Wei, Song Li, Wei Mao, et al.. (2012). Effect of Huxin Formula (护心方) on reverse cholesterol transport in ApoE-gene knockout mice. Chinese Journal of Integrative Medicine. 18(6). 451–456. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact